Leerink Partners, a prominent investment bank focused on the healthcare sector, announced the hiring of Andrew Gitkin as Senior Managing Director for Investment Banking. Gitkin, with over 25 years’ experience across various healthcare-related financial sectors, brings a wealth of knowledge to Leerink, specifically in M&A within ophthalmology and robotic surgery markets. His track record spans prominent firms, relying on his depth of expertise in the field, notably at Raymond James & Associates and PiperJaffray & Company. At Raymond James, he co-led the U.S. healthcare investment banking group as a Senior Managing Director and Vice Chairman. At PiperJaffray, he led the West Coast Biotechnology group, having amassed significant experience in M&A specifically within pharmaceuticals, biotechnology, medical devices, and diagnostics at Moelis & Company. Gitkin’s move to Leerink is positioned as a strategic enhancement of the firm’s investment banking division, in regards to their established reputation and continued success in capital raising and advisory solutions for healthcare companies. He is set to operate from the Miami office under the supervision of Dr. Dan Dubin, Global Co-Head of Investment Banking. His enthusiasm for his new role emphasizes his commitment to furthering Leerink’s legacy of success. The firm’s legacy itself is significant, with over $160 billion raised for clients since its inception, and it holds a unique position as a broker-dealer registered with the SEC and a member of FINRA.

Investment Banking, Healthcare,United States

Leerink Partners Adds Industry Veteran Andrew Gitkin to Healthcare Investment Banking Team